Published on August 19, 2009 at 8:26 AM
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC ), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it will participate in the Southern California Investor Conference being held in Newport Beach, CA, on Tuesday August 18, 2009. IMUC’s President and Chief Executive Officer, Manish Singh, Ph.D., will present an overview of the company’s business and strategy at 1:45pm at the Island Hotel in Newport Beach.
A webcast of this presentation will be available live and by replay. To access both the live and archived webcasts, as well as the slide presentation used during the conference, please go to www.imuc.com
“We are very pleased to have been invited to present at this prestigious gathering of our region’s most promising up and coming companies,” commented Dr. Singh. ”We look forward to having the opportunity to reach a broader investor audience and expect that the occasion will help to significantly raise our exposure to investors who appreciate the type of growth oriented investment that our business presents.”
The conference brings together officers from 30 of Southern California's leading growth oriented companies operating across a breadth of enterprises, including the life sciences, technology, media, and real estate/financial industries with retail and institutional investors from all over the nation.
www.imuc.com
c0384ae0-ba1a-407d-b15d-72453bc1d035|0|.0
Posted in: Miscellaneous News
Tags: Antibody, Biotechnology, Brain, Cancer, Cell, Immunization, Investment, Lung Cancer, Monoclonal Antibody, Pancreatic Cancer, Small Cell Lung Cancer, Stem Cell, Vaccine